NCT01544309
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
See it on ClinicalTrials.gov ↗1,018 people
100%
0 womenmiddle line = equal numbers1,018 men
- Phase
- NA
- Paid for by
- Listen Trial Group
- Finished
- —
- Health conditions
- Hypercholesterolemia With Concomitant Type 2 Diabetes
- Who could join
- Anyone
- Ages
- 20 Years – no maximum
- Average age
- mean 66.4 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Patients who are or may be pregnant”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Patients with serious liver or kidney disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Patients with serious heart failure (NYHA classification III - IV)”
- No diabetes
Women with diabetes were turned away.
“Patients with type 1 diabetes”
- No cancer
Women with current or past cancer were turned away.
“Patients with serious concurrent disease such as malignancy, or patients with severely limited lifespan”
Study titles and rules are shown in their original English.